Aarti Pharmalabs Ltd.

The sales moved up 26.25% to Rs. 4709.47 millions for the December 2024 quarter as compared to Rs. 3730.31 millions during the year-ago period.Net profit surges 52.56% to Rs. 735.23  millions  from Rs. 481.94 millions in the quarter ended December 2024.Operating profit for the quarter ended December 2024 rose to 1269.26 millions as compared to 887.38 millions of corresponding quarter ended December 2023.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202412	202312	% Var	202412	202312	% Var	202403	202303	% Var
Sales	4709.47	3730.31	26.25	12417.27	10873.18	14.20	15021.30	15112.50	-0.60
Other Income	119.36	4.64	2472.41	169.96	53.23	219.29	110.10	12.80	760.16
PBIDT	1269.26	887.38	43.03	3004.14	2441.39	23.05	3571.60	3096.20	15.35
Interest	97.03	43.58	122.65	193.45	122.08	58.46	166.30	204.90	-18.84
PBDT	1172.23	843.80	38.92	2810.69	2319.31	21.19	3405.30	2891.30	17.78
Depreciation	210.43	169.36	24.25	582.29	486.89	19.59	660.10	557.70	18.36
PBT	961.80	674.44	42.61	2228.40	1832.42	21.61	2745.20	2333.60	17.64
TAX	226.57	192.50	17.70	543.36	456.10	19.13	738.70	616.30	19.86
Deferred Tax	51.48	62.50	-17.63	124.66	112.50	10.81	278.10	95.00	192.74
PAT	735.23	481.94	52.56	1685.04	1376.32	22.43	2006.50	1717.30	16.84
Equity	453.13	453.13	0.00	453.13	453.13	0.00	453.10	453.10	0.00
PBIDTM(%)	26.95	23.79	13.30	24.19	22.45	7.75	23.78	20.49	16.05